Skip to content

Efficacy and safety of the Plook-Fire-Thatu recipe on breast milk production: A randomized clinical trial.

Efficacy and safety of the Plook-Fire-Thatu recipe on breast milk production: A randomized clinical trial.

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20240325002
Enrollment
60
Registered
2024-03-25
Start date
2022-03-23
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

1. The effectiveness of the Plook-Fire-Thatu recipe for breastmilk production. 2. Safty of the Plook-Fire-Thatu recipe. Plook-Fire-Thatu galactagogues herbal medicine breastmilk Thai traditional medicine

Interventions

The Plook-Fire-Thatu recipe was made from 11 herbs. Every 100 grams contains 50 grams of Piper nigrum L. and 5 grams of other components. The Plook-Fire-Thatu dosage is 500 mg. Intake before meals thr
Experimental Drug,No Intervention No treatment
Plook Fire Thatu group,Control group

Sponsors

Department of Translational Medicine, Institution of Medicine, Suranaree University of Technology
Lead Sponsor
Thai Traditional Medicine Knowledge Fund, Department of Thai Traditional and Alternative Medicine, Ministry of Public Health, Thailand.,Sikhio Hospital, Nakhon Ratchasima, Thailand
Collaborator

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. postpartum women aged 20 to 40 2. vaginal delivery with a gestational age of 37 weeks or more 3. no abnormalities of the breast and nipple 4. no major complications such as endometritis, sepsis, or bleeding after the delivery

Exclusion criteria

Exclusion criteria: 1. allergy to essential herbs used in the PFT 2. use of drugs that may interact with the recipe (such as phenytoin, propranolol, theophylline, and rifampicin) 3. use of anticoagulant or antiplatelet medication, presence of clinical bleeding, 4. abnormalities in liver or kidney function 5. presence of congenital diseases such as epilepsy, asthma, chronic gastritis, GERD, and high blood pressure.

Design outcomes

Primary

MeasureTime frame
Breastmilk production 3 day postpartum Total breastmilk content and the serum prolactin (PRL) levels

Secondary

MeasureTime frame
Safety 3 day postpartum Hematology, Blood Biochemistry and Adverse drug reaction

Countries

Thailand

Contacts

Public ContactPannida Sintupattanapun

Department of Translational Medicine, Institution of Medicine, Suranaree University of Technology

ppssww002@gmail.com0910219888

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026